Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Equity

v3.23.3
Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   41,736,950    
Beginning balance at Dec. 31, 2021 $ 112,550 $ 417 $ 342,765 $ (230,632)
Increase (Decrease) in Stockholders' Equity        
Net loss (23,533)     (23,533)
Stock-based compensation 11,437   11,437  
Issuance of restricted and performance stock units (in shares)   315,275    
Issuance of restricted and performance stock units 0 $ 3 (3)  
Exercise of stock options and employee stock purchase plan (in shares)   219,998    
Exercise of stock options and employee stock purchase plan 991 $ 3 988  
Ending balance (in shares) at Sep. 30, 2022   42,272,223    
Ending balance at Sep. 30, 2022 101,445 $ 423 355,187 (254,165)
Beginning balance (in shares) at Jun. 30, 2022   42,134,504    
Beginning balance at Jun. 30, 2022 101,690 $ 420 351,117 (249,847)
Increase (Decrease) in Stockholders' Equity        
Net loss (4,318)     (4,318)
Stock-based compensation 3,849   3,849  
Issuance of restricted and performance stock units (in shares)   55,934    
Issuance of restricted and performance stock units 0 $ 1 (1)  
Exercise of stock options and employee stock purchase plan (in shares)   81,785    
Exercise of stock options and employee stock purchase plan 224 $ 2 222  
Ending balance (in shares) at Sep. 30, 2022   42,272,223    
Ending balance at Sep. 30, 2022 $ 101,445 $ 423 355,187 (254,165)
Beginning balance (in shares) at Dec. 31, 2022 42,445,517 42,445,517    
Beginning balance at Dec. 31, 2022 $ 100,999 $ 424 360,155 (259,580)
Increase (Decrease) in Stockholders' Equity        
Net loss (17,823)      
Stock-based compensation 13,091   13,091  
Issuance of restricted and performance stock units (in shares)   356,236    
Issuance of restricted and performance stock units 0 $ 4 (4)  
Exercise of stock options and employee stock purchase plan (in shares)   237,646    
Exercise of stock options and employee stock purchase plan $ 1,543 $ 2 1,541  
Ending balance (in shares) at Sep. 30, 2023 43,039,399 43,039,399    
Ending balance at Sep. 30, 2023 $ 97,810 $ 430 374,783 (277,403)
Beginning balance (in shares) at Jun. 30, 2023   42,979,541    
Beginning balance at Jun. 30, 2023 97,152 $ 430 370,036 (273,314)
Increase (Decrease) in Stockholders' Equity        
Net loss (4,089)      
Stock-based compensation $ 4,747   4,747  
Issuance of restricted and performance stock units (in shares)   59,858    
Ending balance (in shares) at Sep. 30, 2023 43,039,399 43,039,399    
Ending balance at Sep. 30, 2023 $ 97,810 $ 430 $ 374,783 $ (277,403)